Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Syneos Health Inc (SYNH)

Syneos Health Inc (SYNH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,336,675
  • Shares Outstanding, K 104,247
  • Annual Sales, $ 4,676 M
  • Annual Income, $ 131,260 K
  • 60-Month Beta 1.18
  • Price/Sales 0.98
  • Price/Cash Flow 8.45
  • Price/Book 1.50

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate 0.53
  • Number of Estimates 5
  • High Estimate 0.57
  • Low Estimate 0.50
  • Prior Year 0.47
  • Growth Rate Est. (year over year) +12.77%

Price Performance

See More
Period Period Low Period High Performance
1-Month
30.02 +38.57%
on 03/18/20
74.25 -43.97%
on 03/04/20
-21.75 (-34.33%)
since 02/28/20
3-Month
30.02 +38.57%
on 03/18/20
74.25 -43.97%
on 03/04/20
-17.43 (-29.53%)
since 12/27/19
52-Week
30.02 +38.57%
on 03/18/20
74.25 -43.97%
on 03/04/20
-10.16 (-19.63%)
since 03/29/19

Most Recent Stories

More News
Syneos Health Launches Ventilator Initiative to Raise Awareness of Bridging Option to Address Ventilator Shortage for COVID-19 Patients

www.COVID-BiPAPInfo.com Provides Practical Information for Physicians on Innovative Use of BiPAP Machines - Already Available in Many Hospitals - to Potentially Delay or Remove Need for Mechanical Ventilation...

SYNH : 40.31 (-3.10%)
Syneos Health (SYNH) Down 49.8% Since Last Earnings Report: Can It Rebound?

Syneos Health (SYNH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

SYNH : 40.31 (-3.10%)
Syneos Health Grows on New Alliances Amid Regulatory Upheavals

Syneos Health's (SYNH) new partnerships with AiCure and Indegene Omnipresence seem strategic at the moment.

MDT : 91.56 (+1.86%)
RMD : 149.78 (+5.52%)
HRC : 100.93 (+1.41%)
SYNH : 40.31 (-3.10%)
Here's Why You Should Hold Syneos Health in Your Portfolio Now

Syneos Health (SYNH) enjoys high investor confidence on solid prospects.

MDT : 91.56 (+1.86%)
RMD : 149.78 (+5.52%)
HRC : 100.93 (+1.41%)
SYNH : 40.31 (-3.10%)
Syneos Health (SYNH) Tops Q4 Earnings and Revenue Estimates

We are upbeat about the strong year-over-year revenue growth in the Clinical Solutions segment of Syneos Health (SYNH) in Q4.

SYK : 159.75 (+0.33%)
ARAY : 1.6200 (-2.99%)
ABC : 84.59 (+3.44%)
SYNH : 40.31 (-3.10%)
Syneos Health Reports Fourth Quarter and Full Year 2019 Results

Highlights

SYNH : 40.31 (-3.10%)
Syneos Health, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 20, 2020 / Syneos Health, Inc. (NASDAQ:SYNH) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on February 20, 2020 at...

SYNH : 40.31 (-3.10%)
Syneos Health Schedules Fourth Quarter and Year End 2019 Earnings Call for Thursday, February 20, 2020

Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its fourth quarter and year end 2019 financial results on Thursday, February 20, 2020, prior...

SYNH : 40.31 (-3.10%)
Indegene's SaaS Platform For Life Sciences Adds Syneos Health as Strategic Collaborator and Minority Investor

Indegene, a leading Healthcare Tech firm focused on the global life sciences industry, announced Syneos Health (NASDAQ: SYNH) as a strategic collaborator and minority investor in Indegene Omnipresence...

SYNH : 40.31 (-3.10%)
Indegene's SaaS Platform For Life Sciences Adds Syneos Health as Strategic Collaborator and Minority Investor

Indegene, a leading Healthcare Tech firm focused on the global life sciences industry, announced Syneos Health (NASDAQ: SYNH) as a strategic collaborator and minority investor in Indegene Omnipresence...

SYNH : 40.31 (-3.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Trade SYNH with:

Business Summary

Syneos Health Inc. is an integrated biopharmaceutical solutions organization. It includes a Contract Research Organization and Contract Commercial Organization to accelerate customer performance to address modern market realities. Syneos Health Inc., formerly known as INC Research Holdings Inc., is based...

See More

Key Turning Points

2nd Resistance Point 44.39
1st Resistance Point 43.00
Last Price 40.31
1st Support Level 40.49
2nd Support Level 39.37

See More

52-Week High 74.25
Fibonacci 61.8% 57.35
Fibonacci 50% 52.14
Fibonacci 38.2% 46.92
Last Price 40.31
52-Week Low 30.02

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar